Work

Abstract CT167: Phase II study of Nimotuzumab combined with AG regimen in pancreatic cancer with liver metastases (PCLM): A prospective, single-arm trial

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct167

Authors: Dandan Wu, Yang Liu, Linlin Fu, Yinchao Zhang, Linze Xu, Jin Zhang, Huikai Li, Jihui Hao

Institutions: Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409822102

Cites:

Cited by: 1

Related to: 10